On Monday, a group of scientists released findings based on examinations of postmortem samples from dozens of people who died between 1997 and 2024.

The study may suggest that other researchers should be less optimistic about the prospects for treating a range of other ...

Novo Nordisk is under pressure from investors for more information about its next-generation obesity drug candidate CagriSema ...